Botulinum toxin E
- Generic Name
- Botulinum toxin E
A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)
- Conditions
- Glabellar Lines
- Interventions
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 126
- Registration Number
- NCT06834789
- Locations
- 🇺🇸
Investigate MD /ID# 270771, Scottsdale, Arizona, United States
🇺🇸Marcus Facial Plastic Surgery /ID# 270770, Redondo Beach, California, United States
🇺🇸Skin Research Institute LLC /ID# 270831, Coral Gables, Florida, United States
A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 161
- Registration Number
- NCT06308198
- Locations
- 🇨🇳
Beijing Hospital /ID# 256084, Beijing, Beijing, China
🇯🇵Tokyo Center Clinic /ID# 267380, Chuo-ku, Tokyo, Japan
🇨🇳Dermatology Hospital of Southern Medical University /ID# 256172, Guangzhou, Guangdong, China
Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines
- Conditions
- Moderate to Severe Glabellar Lines
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 24
- Registration Number
- NCT06151561
- Locations
- 🇯🇵
Tokyo Center Clinic /ID# 257898, Central District, Tokyo, Japan
A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines
- First Posted Date
- 2022-08-11
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 90
- Registration Number
- NCT05496335
- Locations
- 🇺🇸
The Eye Research Foundation /ID# 244430, Newport Beach, California, United States
🇺🇸DeNova Research /ID# 244421, Chicago, Illinois, United States
🇺🇸Bellaire Dermatology Associates /ID# 244428, Bellaire, Texas, United States
A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 986
- Registration Number
- NCT05248893
- Locations
- 🇺🇸
Perelman Center for Advanced Medicine - /ID# 243966, Philadelphia, Pennsylvania, United States
🇺🇸Northwest Dermatology Institute /ID# 233498, Portland, Oregon, United States
🇺🇸Swinyer-Woseth Dermatology /ID# 241250, Salt Lake City, Utah, United States
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Allergan
- Target Recruit Count
- 309
- Registration Number
- NCT05248880
- Locations
- 🇨🇦
YVR Aesthetics Training & Study Centre /ID# 241858, Vancouver, British Columbia, Canada
🇺🇸Delricht Research - 10154 Jefferson /ID# 244890, Baton Rouge, Louisiana, United States
🇺🇸DMR Research PLLC /ID# 239061, Westport, Connecticut, United States
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 638
- Registration Number
- NCT05248867
- Locations
- 🇺🇸
Clinical Testing of Beverly Hills /ID# 233195, Encino, California, United States
🇺🇸Westside Aesthetics /ID# 232443, Los Angeles, California, United States
🇺🇸Steven Fagien MD Aesthetic Eyelid Plastic Surgery /ID# 232439, Boca Raton, Florida, United States
AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines
- First Posted Date
- 2019-09-19
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Allergan
- Target Recruit Count
- 198
- Registration Number
- NCT04096326
- Locations
- 🇺🇸
DermResearch Inc. /ID# 234483, Austin, Texas, United States
🇺🇸Austin Institute for Clinical Research /ID# 237135, Pflugerville, Texas, United States
🇺🇸Center for Dermatology Clinical Research /ID# 237798, Fremont, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.